SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Lumexa Imaging Holdings, Inc. Common Stock (LMRI) , forward earnings yield 7.64%. PEG 0.75 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
- Forward P/E 13.1
- PEG Ratio 0.75 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
Overall SharesGrow Score: 38/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
✗
HEALTH
17/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — LMRI
Valuation Multiples
P/E (TTM)0.0
Forward P/E13.1
PEG Ratio0.75
Forward PEG0.75
P/B Ratio0.00
P/S Ratio0.69
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.66
Forward EPS (Est.)$0.76
Book Value / Share$0.00
Revenue / Share$14.41
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Forward Earnings Yield7.64%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2023 |
$-1.29 |
$935.93M |
$-122.23M |
-13.1% |
| 2024 |
$-1.00 |
$948.87M |
$-94.1M |
-9.9% |
| 2025 |
$-0.66 |
$1.02B |
$-47.1M |
-4.6% |
